Reference page — cumulative record through Thursday, November 19, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Virtualenv
Product reference — Virtualenv by Pypa · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 21 | 21 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 7.1 | .0021 | 0 | 11 | 7 | 3 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): ▃█▁
| Month | New CVEs |
|---|---|
| 2026-09 | 4 |
| 2026-10 | 17 |
| 2026-11 | 0 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-113726 | 7.8 | 32.6 | HIGH | — | 2026-10-20 |
| CVE-2026-113776 | 7.8 | 22.0 | HIGH | — | 2026-10-20 |
| CVE-2026-113725 | 7.8 | 20.5 | HIGH | — | 2026-10-20 |
| CVE-2026-115586 | 7.1 | 19.6 | HIGH | — | 2026-10-23 |
| CVE-2026-113722 | 7.8 | 18.2 | HIGH | — | 2026-10-20 |
| CVE-2026-113732 | 7.8 | 18.0 | HIGH | — | 2026-10-20 |
| CVE-2026-113715 | 2.0 | 16.1 | LOW | — | 2026-10-20 |
| CVE-2026-113718 | 7.1 | 14.6 | HIGH | — | 2026-10-20 |
| CVE-2026-113723 | 7.1 | 14.6 | HIGH | — | 2026-10-20 |
| CVE-2026-102937 | 7.3 | 11.0 | HIGH | — | 2026-09-29 |
| CVE-2026-113717 | 2.3 | 11.0 | LOW | — | 2026-10-20 |
| CVE-2026-113714 | 2.3 | 10.7 | LOW | — | 2026-10-20 |
| CVE-2026-102930 | 7.7 | 9.5 | HIGH | — | 2026-09-29 |
| CVE-2026-113716 | 4.5 | 9.5 | MEDIUM | — | 2026-10-20 |
| CVE-2026-113719 | 4.5 | 9.5 | MEDIUM | — | 2026-10-20 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-115586 | 7.1 | 19.6 | HIGH | — | 2026-10-23 |
| CVE-2026-113776 | 7.8 | 22.0 | HIGH | — | 2026-10-20 |
| CVE-2026-113721 | 4.5 | 9.5 | MEDIUM | — | 2026-10-20 |
| CVE-2026-113719 | 4.5 | 9.5 | MEDIUM | — | 2026-10-20 |
| CVE-2026-113714 | 2.3 | 10.7 | LOW | — | 2026-10-20 |
| CVE-2026-113724 | 4.5 | 9.5 | MEDIUM | — | 2026-10-20 |
| CVE-2026-113732 | 7.8 | 18.0 | HIGH | — | 2026-10-20 |
| CVE-2026-113723 | 7.1 | 14.6 | HIGH | — | 2026-10-20 |
| CVE-2026-113718 | 7.1 | 14.6 | HIGH | — | 2026-10-20 |
| CVE-2026-113713 | 4.4 | 8.5 | MEDIUM | — | 2026-10-20 |
| CVE-2026-113726 | 7.8 | 32.6 | HIGH | — | 2026-10-20 |
| CVE-2026-113722 | 7.8 | 18.2 | HIGH | — | 2026-10-20 |
| CVE-2026-113715 | 2.0 | 16.1 | LOW | — | 2026-10-20 |
| CVE-2026-113725 | 7.8 | 20.5 | HIGH | — | 2026-10-20 |
| CVE-2026-113716 | 4.5 | 9.5 | MEDIUM | — | 2026-10-20 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Pypa — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.